ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KRTX Karuna Therapeutics Inc

329.83
0.00 (0.00%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Karuna Therapeutics Inc KRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 329.83 20:00:00
Open Price Low Price High Price Close Price Prev Close
329.83 329.83
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/11/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202417:01EDGAR2Form 144 - Report of proposed sale of securities
3/01/202406:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
3/01/202406:01EDGAR2Form 8-K - Current report
2/22/202406:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/202406:32EDGAR2Form 8-K - Current report
2/22/202406:30BWKaruna Therapeutics Reports Fourth Quarter and Full Year..
2/15/202416:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202416:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202410:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202417:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202411:56EDGAR2Form 144 - Report of proposed sale of securities
2/05/202416:12EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
1/22/202406:05EDGAR2Form PREM14A - Preliminary proxy statements relating to..
1/16/202416:18EDGAR2Form 8-K - Current report
1/09/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202416:18EDGAR2Form 144 - Report of proposed sale of securities
1/08/202410:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
12/29/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202317:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202317:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202317:07EDGAR2Form 8-K - Current report
12/22/202316:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202316:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202315:30PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
12/22/202311:15DJNTrending: Bristol Myers to Buy Karuna Therapeutics for $14..
12/22/202308:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/22/202308:26EDGAR2Form 8-K - Current report
12/22/202307:05BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
12/22/202306:59BWBristol Myers Squibb Strengthens Neuroscience Portfolio with..
12/14/202318:30BWKaruna Therapeutics Announces The Lancet Publication of Data..
12/12/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202315:24EDGAR2Form 144 - Report of proposed sale of securities
11/29/202310:17BWPureTech Founded Entity Karuna Therapeutics Announces U.S...
11/29/202307:13DJNKaruna Therapeutics Gets FDA Acceptance for KarXT NDA
11/29/202306:30BWKaruna Therapeutics Announces U.S. Food and Drug..
11/16/202316:01BWKaruna Therapeutics Announces Positive Results from Phase 1b..
11/13/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202316:25EDGAR2Form 144 - Report of proposed sale of securities
11/02/202306:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202306:36EDGAR2Form 8-K - Current report
11/02/202306:30BWKaruna Therapeutics Reports Third Quarter 2023 Financial..
11/01/202306:45BWKaruna Therapeutics to Present Data from the EMERGENT..
11/01/202306:30BWKaruna Therapeutics to Present at Upcoming Investor..
10/19/202306:30BWKaruna Therapeutics to Announce Third Quarter 2023 Financial..
10/10/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock